Pricing and reimbursement mechanisms for advanced therapy medicinal products in 20 countries.

ABSTRACT: Introduction: Advanced Therapy Medicinal Products are a type of therapies that, in some cases, hold great potential for patients without an effective current therapeutic approach but they also present multiple challenges to payers. While there are many theoretical papers on pricing and reimbursement (P&R) options, original empirical research is very scarce. This paper aims to provide a comprehensive international review of regulatory and P&R decisions taken for all ATMPs with centralized European marketing authorization in March 2022. Methods: A survey was distributed in July 2022 to representatives of 46 countries. Results: Responses were received from 20 countries out of 46 (43.5%). 14 countries reimbursed at least one ATMP. Six countries in this survey reimbursed no

SUBMITTER: Rejon-Parrilla JC 

PROVIDER: S-EPMC10715052 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature